Dihydroergotamine (DHE) Use during Gestation and the Risk of Adverse Pregnancy Outcomes

被引：0
|
作者：
Berard, A. [1 ,2 ]
Sheehy, O. [2 ]
Kori, S. H. [3 ]
机构：
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[2] CHU Ste Justine, Res Ctr, Montreal, PQ, Canada
[3] MAP Pharmaceut Inc, Clin Dev & Med Affairs, Mountain View, CA USA
来源：
HEADACHE | 2011年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [21] Gabapentin Use During Pregnancy and the Risk of Adverse Neonatal Birth Outcomes in two Canadian provinces
    Lavu, Alekhya
    Peymani, Payam
    Alessi-Severini, Silvia
    Ruth, Chelsea
    Falk, Jamison
    Kowalec, Kaarina
    Leong, Christine
    Derksen, Shelley
    Dragan, Roxana
    Marcus Ng
    Winquist, Brandace
    Delaney, Joseph
    Eltonsy, Sherif
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 662 - 662
  • [22] Partner violence during pregnancy increases risk of adverse outcomes
    Rosenberg, J
    PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2003, 35 (05) : 238 - 239
  • [23] Investigation of Metronidazole Use during Pregnancy and Adverse Birth Outcomes
    Koss, Catherine A.
    Baras, Dana C.
    Lane, Sandra D.
    Aubry, Richard
    Marcus, Michele
    Markowitz, Lauri E.
    Koumans, Emilia H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4800 - 4805
  • [24] Increased Risk of Adverse Pregnancy Outcomes in Women Receiving Zolpidem During Pregnancy
    Wang, L-H
    Lin, H-C
    Lin, C-C
    Chen, Y-H
    Lin, H-C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 369 - 374
  • [25] PAROXETINE USE DURING PREGNANCY AND ADVERSE PREGNANCY OUTCOMES IN THE ABSENCE OF DETECTION BIAS
    Berard, A.
    Sheehy, O.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [26] Teen pregnancy and risk for adverse pregnancy outcomes
    Staniczenko, Anna P.
    Wen, Timothy
    Krenitsky, Nicole
    D'Alton, Mary E.
    Friedman, Alexander M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S541 - S541
  • [27] Use of Dihydroergotamine (DHE) Should Be Restricted to No More Than Twice a Week
    Tfelt-Hansen, Peer C.
    Diener, Hans-Christoph
    HEADACHE, 2014, 54 (09): : 1523 - 1525
  • [28] Risk of Adverse Pregnancy Outcomes in Women With Mild Chronic Hypertension Before 20 Weeks of Gestation
    Ankumah, Nana-Ama
    Cantu, Jessica
    Jauk, Victoria
    Biggio, Joseph
    Hauth, John
    Andrews, William
    Tita, Alan Thevenet N.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 (05): : 966 - 972
  • [29] The Use of Twin Gestation Specific TSH Reference Ranges and the Association With Adverse Pregnancy Outcomes.
    Rosner, Jonathan
    Rebarber, Andrei
    Saltzman, Daniel
    Klauser, Chad
    Fox, Nathan
    Gupta, Simi
    REPRODUCTIVE SCIENCES, 2015, 22 : 349A - 350A
  • [30] Maternal Depression and Use of Antidepressants During Pregnancy Increase the Risk of Adverse Pregnancy Outcomes: An IPD Meta-Analysis
    Vlenterie, Richelle
    van Gelder, Marleen
    Pop-Purceleanu, Monica
    Roeleveld, Nel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 328 - 329
12345